BDMS Bangkok Hospital and Samitivej Hospital, win 8 Global Health and Travel Awards for the third consecutive year

Food and Healthcare Press Releases Wednesday May 16, 2018 16:01
Bangkok--16 May--

For the third consecutive year, Bangkok Hospital and Samitivej Hospital, members of Bangkok Dusit Medical Services (BDMS), won 8 Global Health and Travel Awards (GHT Awards), at the 2018 Asia Pacific Healthcare & Medical Tourism Summit, the leading healthcare podium, which is a collaboration between Global Health & Travel and AB Bernstein.

Mr. Buranut Limjitti, Senior Vice President of International Marketing, Advertising & PR, BDMS, revealed after his speech at the premier healthcare gathering held in Ho Chi Minh City, Vietnam, that Bangkok Hospital won 5 awards, including Hospital of The Year in Asia Pacific 2018, Hospital of The Year Thailand 2018, Orthopaedic Service Provider of The Year in Asia Pacific 2018, Transplant Service Provider of The Year in Asia Pacific 2018 and Neurology Service Provider of The Year in Asia Pacific 2018, and Samitivej Hospital won 3 awards, which are Paediatric Service Provider of The Year in Asia Pacific 2018, Cosmetic Surgery Provider of The Year in Asia Pacific 2018, Gastroenterology Service Provider of the Year in Asia Pacific 2018.

Nisarat Jaidee, M.D., Samitivej Referral & Assistance Center Director and Assistant Hospital Director, Samitivej Sukhumvit Hospital, said that it was an honour to win this award, which recognized the hospital that maintained consistently high standards. These awards emphasized the hospital's outstanding performance in terms of initiatives that can improve the way healthcare is delivered through areas such as leadership, technological innovation, personnel and customer service.

Asawin Puwatanasan, M.D., Assistant Hospital Director, Bangkok Hospital, revealed that Bangkok Hospital committed to improve the standard of healthcare and customer value through all aspects, including; technological clinical innovation, specialist recruitment and development, research and development, networking and co-program with leading hospitals/ institute globally, as well as customer service, which resulted in the recognition by global institutes.

Buranut concluded that hospitals in BDMS network, including: Bangkok Hospitals, Samitivej Hospitals and Phyathai Hospitals, provided world class patients services ranging from primary preventative to super tertiary care. With the reputation, expertise, accomplishment and credibility of BDMS' Centers of Excellence Network, the number of domestic and international patients has increased continuously. BDMS committed to improve the capability of all 45 hospitals and medical facilities to be able to provide the world class professional quality service throughout the network. Across any of BDMS' healthcare facilities, patients can be assured of receiving clinical care that compares with the international standards.


Latest Press Release

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health...

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R)

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European...

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation...

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

Related Topics